Medical Properties Trust - MPW Stock Forecast, Price & News

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Medical Properties Trust in the last twelve months. There are currently 5 hold ratings, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MPW shares.
View MPW analyst ratings or view top-rated stocks.

9 brokers have issued 1 year target prices for Medical Properties Trust's stock. Their MPW share price forecasts range from $10.00 to $18.00. On average, they anticipate the company's share price to reach $14.82 in the next year. This suggests a possible upside of 96.8% from the stock's current price.
View analysts price targets for MPW or view top-rated stocks among Wall Street analysts.

Medical Properties Trust's stock was trading at $11.14 on January 1st, 2023. Since then, MPW shares have decreased by 32.4% and is now trading at $7.53.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 27th 2023.
View our MPW earnings forecast.

Medical Properties Trust, Inc. (NYSE:MPW) released its quarterly earnings data on Thursday, April, 28th. The real estate investment trust reported $1.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.58. The real estate investment trust earned $409.80 million during the quarter, compared to analyst estimates of $413.31 million. Medical Properties Trust had a net margin of 58.50% and a trailing twelve-month return on equity of 10.25%. The firm's quarterly revenue was up 13.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.42 EPS.

Medical Properties Trust announced a quarterly dividend on Thursday, February 16th. Stockholders of record on Thursday, March 16th will be given a dividend of $0.29 per share on Thursday, April 13th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 15.41%. The ex-dividend date of this dividend is Wednesday, March 15th.
Read our dividend analysis for MPW.

ETFs with the largest weight of Medical Properties Trust (NYSE:MPW) stock in their portfolio include BNY Mellon Global Infrastructure Income ETF (BKGI), Invesco KBW Premium Yield Equity REIT ETF (KBWY), ALPS REIT Dividend Dogs ETF (RDOG), iShares Residential and Multisector Real Estate ETF (REZ), Franklin U.S. Low Volatility High Dividend Index ETF (LVHD), John Hancock U.S. High Dividend ETF (JHDV), Hoya Capital High Dividend Yield ETF (RIET) and Trajan Wealth Income Opportunities ETF (TWIO).

Medical Properties Trust (NYSE:MPW) pays an annual dividend of $1.16 per share and currently has a dividend yield of 15.96%. MPW has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 8 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 77.33%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, MPW will have a dividend payout ratio of 71.17% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MPW.

Medical Properties Trust updated its FY 2023 earnings guidance on Thursday, February, 23rd. The company provided EPS guidance of $1.50-$1.65 for the period, compared to the consensus estimate of $1.75. The company issued revenue guidance of -.

Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Properties Trust investors own include AT&T (T), Verizon Communications (VZ), Energy Transfer (ET), Enterprise Products Partners (EPD), Omega Healthcare Investors (OHI), New Residential Investment (NRZ), Cisco Systems (CSCO), Pfizer (PFE), AbbVie (ABBV) and Intel (INTC).

Medical Properties Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "MPW."

Medical Properties Trust's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Principal Financial Group Inc. (3.35%), Centersquare Investment Management LLC (1.85%), Geode Capital Management LLC (1.74%), Morgan Stanley (1.49%), Dimensional Fund Advisors LP (1.34%) and Charles Schwab Investment Management Inc. (1.06%). Insiders that own company stock include Edward K Aldag Jr, Emmett E Mclean, James Kevin Hanna, Michael G Stewart and R Steven Hamner.
View institutional ownership trends.

Shares of MPW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MPW stock can currently be purchased for approximately $7.53.

Medical Properties Trust (NYSE:MPW) has a market capitalization of $4.51 billion and generates $1.54 billion in revenue each year. The real estate investment trust earns $902.60 million in net income (profit) each year or $1.50 on an earnings per share basis.

The company employs 112 workers across the globe.

Medical Properties Trust's mailing address is 1000 URBAN CENTER DRIVE SUITE 501, BIRMINGHAM AL, 35242. The official website for the company is www.medicalpropertiestrust.com. The real estate investment trust can be reached via phone at (205) 969-3755, via email at tberryman@medicalpropertiestrust.com, or via fax at 205-969-3756.